骨肉瘤基因治疗研究进展
丁凡;邵增务;
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 丁凡;邵增务;
Email:
DOI:
参考文献(References)：
- [1]Lafleur EA,Jia SF,Worth LL,et al.Interleukin(IL)-12and IL-12gene transfer up regulate Fas expression in human osteosareoma and breast cancer cells[J].Cancer Res,2001,61:4066-4071.
- [2]De Wilt JH,Bout A,eggernmont AM,et al.Adenovirus-mediated interteukin3beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats[J].Hum Gene Ther,2001,12:489-502.
- [3]Nagamori M,Kawaguchi S,Murakimi M,et al.In vivo immunogenic-ity of osteosarcoma cells that express B7-1a,an alternatively spliced form of BT-i[J].Anticancer Res,2002,22:2009-2013.
- [4]Luksch R,Perotti D,Cefalo G,et al.Immunomodulation in a treat-ment program including pre-and post-operative interleukin-2and chemotherapy for childhood osteosarcoma[J].Tumori,2003,89:263-268.
- [5]Baamonde A,Curto-Reyes V,Judrez L,et al.Antihyperalgesic effects induced by the IL-1receptor antagonist anakinra and in-creased IL-1levels in inflamed and osteosarcoma-bearing mice[J].Life Sci,2007,81:673-682.
- [6]Liebau C,Roesel C,Schmidt S,et al.Immunotherapy by gene trans-fer with plasmids encoding IL-12/IL-18is superior to IL-23/IL-18gene transfer in a rat osteosarcoma model[J].Antieancer Res,2004,24:2861-2867.
- [7]Todesco A,Carli M,Iacona I,et al.All-trans retinoic acid and in-terferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma[J].Cancer,2000,89:2661-2666.
- [8]Strander H.Interferons and osteosarcoma[J].Cytokine Growth Factor Rev,2007,18:373-380.
- [9]Fulda S,Debatin KM.5-Aza-2’-deoxycytidine and IFN-gam-ma cooperate to sensitize for TRAIL-induced apoptosis by upregulat-ing caspase-8[J].Oncogene,2006,25:5125-5133.
- [10]Ragland BD,Bell W C,Lopez RR,et al.Cytogenetics and molecular biology of osteosarcoma[J].Lab Invest,2002,82:365-373.
- [11]Xie XK,Yang DS,Ye ZM,et al.Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcomacell lines MG-63and U2OS[J].Cancer,2005,24:292-297.
- [12]Martelli L,Di Marlo F,Botti P,et al.Accumulation,platinum-DNA adduct formation and cytotoxicity of cisplatin,oxaliplatin and sa-traplatin in sensitive and resistant human osteosarcoma cell lines,char-acterized by p53wild-type status[J].Biochem Pharmacol,2007,74:20-27.
- [13]Tsang WP,Chau SP,Fung KP,et al.Modulation of multidrug resist-ance-associated protein I(MRP1)by p53mutant in Saos-2cells[J].Cancer Chemother Pharmacol,2003,51:161-166.
- [14]Sero M,Yamazaki T,Sonoda J,et al.Suppression of tumor growth and pulmonary metastasis in murineosteosarcoma using gene therapy[J].Oncol Rep,2002,9:337-340.
- [15]Ketola A,Maatta AM,Pasanen T,et al.Osteosarcoma and chondrosar-coma as targets for virus vectors and herpes simplexvirus thymidine ki-nase/ganciclovir gene therapy[J].Int J Mol Med,2004,13:705-710.
- [16]Ramnaraine M,Pan W,Gohlirsch M,et al.Direct and bystander kill-ing of sarcomas by novel cytosinedeaminase fusion gene[J].Cancer Res,2003,63:6847-6854.
- [17]Oosterhoff D,Witlox MA,van Beusechem VW,et al.Gene-directed enzyme prodrug therapy for osteosarcoma:sensitization to CPT-11in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase-2[J].Mol Cancer Ther,2003,2:765-771.
- [18]Dass CR,Contreras KG,Dunstan DE,et al.Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic me-tastatic model of osteosarcoma[J].Biomaterials,2007,28:3026-3033.
- [19]Okumura K,Nakase M,Nakamura S,et al.Bax gene therapy for os-teosarcoma using cationic liposomes in vivo[J].Once1Rep,2007,17:769-780.
- [20]Nakase M,Inui M,Okumura K,et al.P53gene therapy of human os-teosarcoma using a transferrin-modified cationic liposome[J].Mol-cancer Ther,2005,4:625-631.
- [21]Kanerva A,Hemminki A.Adenoviruses for treatment of cancer[J].Ann Med,2005,37:33-43.
- [22]Ganjavi H,Gee M,Narendran A,et al.Adenovirus-mediated P53gene therapy in osteosarcoma cell lines:sensitization to cisplatin and doxorubicin[J].Cancer Gene Ther,2006,13:415-419.